Cover Image

HIV-1 diversity considerations for clinical studies of passively transferred broadly neutralising antibodies

Saved in:

Bibliographic Details
Main Authors:	K. Wagh (Author), K. Stephenson (Author), D. Barouch (Author), B. Korber (Author)
Format:	Book
Published:	Elsevier, 2019-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Modulated production of endogenous anti-HIV broadly neutralising antibodies
by: Y. Gao, et al.
Published: (2019)

Evaluation of the in vivo capacity of broadly neutralising anti-HIV antibodies to eliminate latently infected cells from HIV-infected individuals using a novel humanised mouse model
by: N. Flerin, et al.
Published: (2017)

Neutralising antibodies and virus isolation: The keys to control covert COVID-19 spread?
by: Grégoire B. Morand
Published: (2021)

Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic
by: David A. Spencer, et al.
Published: (2021)

Diverse HIV-1 escape pathways from broadly neutralizing antibody PGDM1400 in humanized mice
by: Yme U. van der Velden, et al.
Published: (2020)

Neonatal Multisystem Inflammatory Syndrome Associated with Passive Transfer of Antibodies
by: Lokeswari Balleda, et al.
Published: (2021)

Broadly neutralizing antibodies in HIV-1 treatment and prevention
by: Rajesh Kumar, et al.
Published: (2018)

Broadly neutraliing antibody cocktail prevents the establishment of viral reservoir against a mixed SHIV challenge
by: P.-T. Liu, et al.
Published: (2017)

7 Presence of HIV-1C broadly neutralizing antibodies in pregnancy and at delivery
by: T. Mduluza, et al.
Published: (2016)

Rabies virus-neutralising antibodies in healthy, unvaccinated individuals: What do they mean for rabies epidemiology?
by: Susannah Gold, et al.
Published: (2020)

Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV
by: Bryan T. Mayer, et al.
Published: (2024)

Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre cohort study
by: Andrea Lombardi, et al.
Published: (2022)

Exploration of broadly neutralizing antibody fragments produced in bacteria for the control of HIV
by: Sarah B. Lloyd, et al.
Published: (2017)

Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms.
by: Nessrin Alomran, et al.
Published: (2021)

Passive and active antibody studies in primates to inform HIV vaccines
by: Ann J. Hessell, et al.
Published: (2018)

Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolation
by: Hannah Taylor, et al.
Published: (2021)

Correction: Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms.
by: Nessrin Alomran, et al.
Published: (2022)

Correction: Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms
by: Nessrin Alomran, et al.
Published: (2022)

PP 8.8 - 00129 Antibody mediated killing of HIV-1 infected cells with glycoengineered broadly neutralizing antibodies
by: S. De Taeye, et al.
Published: (2022)

Prevalence of neutralising antibodies against SARS-CoV-2 in acute infection and convalescence: A systematic review and meta-analysis.
by: Helen R Savage, et al.
Published: (2021)

Pregnancy-associated thrombotic thrombocytopenic purpura complicated by Sjögren's syndrome and non-neutralising antibodies to ADAMTS13: a case report
by: Lu Zhou, et al.
Published: (2021)

To prescreen or not to prescreen for broadly neutralizing antibody sensitivity in HIV cure-related trials
by: Hursch Patel, et al.
Published: (2023)

Removal of variable domain N-linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies
by: Gwo-Yu Chuang, et al.
Published: (2020)

Seroprevalence of SARS-CoV-2 neutralising antibodies and cross-reactivity to JN.1 one year after the BA.5/BF.7 wave in China
by: Xue-Dong Song, et al.
Published: (2024)

Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration.
by: Geremew Tasew, et al.
Published: (2010)

Antibody-dependent passive protection of mucosal surfaces
by: Jiri Mestecky
Published: (2022)

Neutralising effects of small molecule toxin inhibitors on nanofractionated coagulopathic Crotalinae snake venoms
by: Chunfang Xie, et al.
Published: (2020)

Passive immunization with influenza haemagglutinin specific monoclonal antibodies
by: Rajeev Rudraraju, et al.
Published: (2018)

Strategies to induce broadly protective antibody responses to viral glycoproteins
by: F Krammer
Published: (2017)

Why Does the Molecular Structure of Broadly Neutralizing Monoclonal Antibodies Isolated from Individuals Infected with HIV-1 not Inform the Rational Design of an HIV-1 Vaccine?
by: Marc H V Van Regenmortel
Published: (2015)

Clip thinking as a consequence of virtual communication: Pedagogical methods of neutralisation in foreign language lessons
by: O. Boiko
Published: (2023)

Immunogenicity of an adjuvanted broadly active influenza vaccine in immunocompromised and diverse populations
by: Dylan A. Hendy, et al.
Published: (2024)

Novel immunological strategies for HIV-1 eradication
by: B. Jülg, et al.
Published: (2015)

Developability considerations for bispecific and multispecific antibodies
by: Alaa Amash, et al.
Published: (2024)

Point of care detection of SARS-CoV-2 antibodies and neutralisation capacity-lateral flow immunoassay evaluation compared to commercial assay to inform potential role in therapeutic and surveillance practices
by: Jonathan McGrath, et al.
Published: (2023)

T cell-based strategies for HIV-1 vaccines
by: Bette Korber, et al.
Published: (2020)

Assessing the failure in transfer of passive immunity in beef calves: two case reports
by: Carolina Balao Silva, et al.
Published: (2020)

Prospects for a HIV vaccine
by: Dan Barouch
Published: (2016)

DNA sequence variants in the LOXL1 gene are associated with pseudoexfoliation glaucoma in a U.S. clinic-based population with broad ethnic diversity
by: Miller Joan W, et al.
Published: (2008)

A Broad Consideration of Risk Factors in Pediatric Chronic Pain: Where to Go from Here?
by: Hannah N. McKillop, et al.
Published: (2016)